ClearPoint Neuro Inc vs Synchrony Financial — how do they compare? ClearPoint Neuro Inc trades at $14.86 (market cap $454.21M), while Synchrony Financial trades at $78.37 (market cap $25.53B). The key difference: Synchrony Financial is far larger — about 56.2× ClearPoint Neuro Inc's market cap, and Synchrony Financial pays a 1.73% dividend while ClearPoint Neuro Inc pays none. Which is the better fit depends on your goals.
| CLPT | SYF | |
|---|---|---|
Market Cap | $454.21M | $25.53B |
Sector | Health | Financials |
52-Week High | $29.60 | $88.47 |
52-Week Low | $8.66 | $63.78 |
Enterprise Value | $488.79M | — |
Dividend Yield | — | 1.73% |
Trailing returns across standard periods
Latest headlines on both assets
ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.
Read more on CLPT →Synchrony Financial is a premier consumer financial services company and the largest provider of private-label credit cards in the United States. Spun off from GE Capital in 2014, it operates through a unique B2B2C model, embedding its financing products within the ecosystems of major partners like Amazon, Lowe’s, and PayPal. Synchrony leverages deep data analytics and a diverse multi-platform strategy—spanning retail, health, and auto—to drive customer loyalty and provide specialized credit solutions at the point of sale.
Read more on SYF →